“Cholesterol Levels”的搜索结果，显示 431-440 项，共有 13690 项

1. 血液科- 临床试验- 妙佑医疗国际

   Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

2. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   The purpose of this research study to compare the effects a hormone cholecystokinin (CCK) in the bloodstream in healthy people and in patients with rapid ...

3. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate changes in CSF dynamics (e.g., velocity, flow rate) between patients with normal pressure hydrocephalus and healthy ...

4. 肾病和高血压- 临床试验- 妙佑医疗国际

   The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients with critical ...

5. 冠状动脉钙化扫描- 医生与科室- 妙佑医疗国际

   Skip to content ... Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol ... and-tests/ ...

6. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

7. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the immune and hematopoietic compartments in ... The drug combination of acalabrutinib, durvalumab, and venetoclax is ...

8. 心血管医学- 临床试验- 妙佑医疗国际

   The purpose of this study is to validate novel echocardiographic parameters and algorithms to quantitatively evaluate right ventricular function in patients ...

9. 血液科- 临床试验- 妙佑医疗国际

   The overall goal of this study is to understand if adding inotuzumab ozogamicin to standard of care chemotherapy maintains or improves outcomes in High Risk B- ...

10. 外科 - 临床试验- 妙佑医疗国际

    The purpose of this study is to further characterize the serum and Cerebral Spinal Fluid (CSF) biomarker profile of idiopathic normal pressure hydrocephalus ...